Cardiologia Pediátrica

Estudo de coorte | Características clínicas e história natural da cardiomiopatia hipertrófica não sindrômica em pré-adolescentes.

24 Mai, 2022 | 11:24h

Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy – Journal of the American College of Cardiology

Comentário: Clinical Features and Course of Preadolescent Hypertrophic Cardiomyopathy – American College of Cardiology

---

Posicionamento científico | Diagnóstico e tratamento de cardiomiopatias raras em pacientes adultos e pediátricos.

4 Mai, 2022 | 13:24h

Diagnosis and Management of Rare Cardiomyopathies in Adult and Paediatric Patients. A Position Paper of the Italian Society of Cardiology (SIC) and Italian Society of Paediatric Cardiology (SICP) – International Journal of Cardiology

---

Diretriz científica AHA | Infecção por SARS-CoV-2 e manifestações cardiovasculares associadas em crianças e jovens adultos.

14 Abr, 2022 | 16:59h

SARS-CoV-2 Infection and Associated Cardiovascular Manifestations and Complications in Children and Young Adults: A Scientific Statement From the American Heart Association – Circulation

Comunicado de imprensa: Heart issues after COVID-19 uncommon in children and young adults, more research needed – American Heart Association

Comentário: COVID-19 CV Complications in Children Are Rare, Treatable: AHA Statement – TCTMD

---

Revisão de diretrizes nacionais | Fase aguda da doença de Kawasaki.

14 Abr, 2022 | 16:31h

Acute phase of Kawasaki disease: a review of national guideline recommendations – European Journal of Pediatrics

---

Diretriz científica AHA | Abordagem dos determinantes sociais de saúde e mitigação de disparidades de saúde ao longo da vida na doença cardíaca congênita.

12 Abr, 2022 | 12:29h

Addressing Social Determinants of Health and Mitigating Health Disparities Across the Lifespan in Congenital Heart Disease: A Scientific Statement From the American Heart Association – Circulation

Comentário: Social determinants of health affect care for people with congenital heart disease – American Heart Association

---

Revisão | Epigenética na doença cardíaca congênita.

11 Abr, 2022 | 12:45h

Epigenetics in Congenital Heart Disease – Journal of the American Heart Association

---

Estudo de coorte | Fatores de risco cardiovascular na infância e eventos cardiovasculares na vida adulta.

6 Abr, 2022 | 12:30h

Childhood Cardiovascular Risk Factors and Adult Cardiovascular Events – New England Journal of Medicine (link para o resumo – $ para o texto completo)

 

Comentário no Twitter

Childhood cardiovascular risk factors including BMI, systolic blood pressure, lipid levels, and smoking were correlated with cardiovascular events in adulthood after a mean follow-up of 35 years. #ACC22 https://t.co/fh2SoQ09Qq pic.twitter.com/cZiYYGEubF

— NEJM (@NEJM) April 4, 2022

 

---

Metanálise de 56 estudos randomizados controlados | Intervenções farmacológicas para doença de Kawasaki em crianças.

1 Abr, 2022 | 12:59h

Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials – eBioMedicine

Comentário: Network meta-analysis rates treatments for Kawasaki disease – medwire News

---

Revisão | Morte súbita cardíaca na doença cardíaca congênita.

31 Mar, 2022 | 13:20h

Sudden cardiac death in congenital heart disease – European Heart Journal

 

Comentário no Twitter

Sudden cardiac death in congenital heart disease – state-of-the-art review https://t.co/Oz5Lbp8XKZ @escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes pic.twitter.com/Bu6m4tK8rL

— European Society of Cardiology Journals (@ESC_Journals) March 28, 2022

 

---

Miocardite e pericardite após vacinação contra COVID-19: diretriz para profissionais da saúde.

29 Mar, 2022 | 15:13h

Myocarditis and pericarditis after COVID-19 vaccination: clinical management guidance for healthcare professionals – UK Health Security Agency

Conteúdos relacionados:

Myocarditis following a third Pfizer vaccination dose in military recruits in Israel.

Myocarditis following COVID-19 BNT162b2 vaccination among adolescents in Hong Kong.

[Preprint] Post-marketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12-39 years in Italy.

Myocarditis after BNT162b2 vaccination in Israeli adolescents.

Myocarditis cases reported after mRNA-Based COVID-19 vaccination in the US from December 2020 to August 2021.

A case-control study showed an increased risk of myocarditis after COVID-19 vaccination with a messenger RNA vaccine compared to an inactivated virus vaccine.

[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.

Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination vs. SARS-CoV-2 infection.

Case series with 139 adolescents and young adults with suspected myocarditis following mRNA vaccination showed most cases had a mild clinical course and rapid resolution of symptoms.

Heart-inflammation risk from Pfizer COVID vaccine is very low.

Large cohort study with over 2.5 million individuals showed the incidence of myocarditis after the Pfizer vaccine was 2.13 cases per 100,000 persons.

Study with over 5.1 million vaccinated individuals showed the incidence of myocarditis after the receipt of the Pfizer vaccine was low and more common after the second dose in young male recipients.

Large Observational study shows Pfizer Covid vaccine is mostly safe but is associated with increased risk of myocarditis, adenopathy, appendicitis, and herpes zoster.

---